Overactive Bladder Therapeutics Market
1 Study Coverage
1.1 Overactive Bladder Therapeutics Revenue in Overactive Bladder Therapeutics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Overactive Bladder Therapeutics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Overactive Bladder Therapeutics Market Size for the Year 2017-2028
1.2.2 Global Overactive Bladder Therapeutics Market Size for the Year 2017-2028
1.3 Overactive Bladder Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Overactive Bladder Therapeutics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Overactive Bladder Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Overactive Bladder Therapeutics Market Dynamics
1.4.1 Overactive Bladder Therapeutics Industry Trends
1.4.2 Overactive Bladder Therapeutics Market Drivers
1.4.3 Overactive Bladder Therapeutics Market Challenges
1.4.4 Overactive Bladder Therapeutics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Overactive Bladder Therapeutics by Type
2.1 Overactive Bladder Therapeutics Market Segment by Type
2.1.1 Anticholinergics
2.1.2 Mirabegron
2.1.3 Botox
2.2 Global Overactive Bladder Therapeutics Market Size by Type (2017, 2022 & 2028)
2.3 Global Overactive Bladder Therapeutics Market Size by Type (2017-2028)
2.4 United States Overactive Bladder Therapeutics Market Size by Type (2017, 2022 & 2028)
2.5 United States Overactive Bladder Therapeutics Market Size by Type (2017-2028)
3 Overactive Bladder Therapeutics by Application
3.1 Overactive Bladder Therapeutics Market Segment by Application
3.1.1 Idiopathic Overactive Bladder
3.1.2 Neurogenic Overactive Bladder
3.2 Global Overactive Bladder Therapeutics Market Size by Application (2017, 2022 & 2028)
3.3 Global Overactive Bladder Therapeutics Market Size by Application (2017-2028)
3.4 United States Overactive Bladder Therapeutics Market Size by Application (2017, 2022 & 2028)
3.5 United States Overactive Bladder Therapeutics Market Size by Application (2017-2028)
4 Global Overactive Bladder Therapeutics Competitor Landscape by Company
4.1 Global Overactive Bladder Therapeutics Market Size by Company
4.1.1 Top Global Overactive Bladder Therapeutics Companies Ranked by Revenue (2021)
4.1.2 Global Overactive Bladder Therapeutics Revenue by Player (2017-2022)
4.2 Global Overactive Bladder Therapeutics Concentration Ratio (CR)
4.2.1 Overactive Bladder Therapeutics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Overactive Bladder Therapeutics in 2021
4.2.3 Global Overactive Bladder Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Overactive Bladder Therapeutics Headquarters, Revenue in Overactive Bladder Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Overactive Bladder Therapeutics Headquarters and Area Served
4.3.2 Global Overactive Bladder Therapeutics Companies Revenue in Overactive Bladder Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Overactive Bladder Therapeutics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Overactive Bladder Therapeutics Market Size by Company
4.5.1 Top Overactive Bladder Therapeutics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Overactive Bladder Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global Overactive Bladder Therapeutics Market Size by Region
5.1 Global Overactive Bladder Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Overactive Bladder Therapeutics Market Size by Region (2017-2028)
5.2.1 Global Overactive Bladder Therapeutics Market Size by Region: 2017-2022
5.2.2 Global Overactive Bladder Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Overactive Bladder Therapeutics Market Size YoY Growth 2017-2028
6.1.2 North America Overactive Bladder Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Overactive Bladder Therapeutics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Overactive Bladder Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Overactive Bladder Therapeutics Market Size YoY Growth 2017-2028
6.3.2 Europe Overactive Bladder Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Overactive Bladder Therapeutics Market Size YoY Growth 2017-2028
6.4.2 Latin America Overactive Bladder Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Overactive Bladder Therapeutics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Overactive Bladder Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Astellas Pharma
7.1.1 Astellas Pharma Company Details
7.1.2 Astellas Pharma Business Overview
7.1.3 Astellas Pharma Overactive Bladder Therapeutics Introduction
7.1.4 Astellas Pharma Revenue in Overactive Bladder Therapeutics Business (2017-2022)
7.1.5 Astellas Pharma Recent Development
7.2 Allergan
7.2.1 Allergan Company Details
7.2.2 Allergan Business Overview
7.2.3 Allergan Overactive Bladder Therapeutics Introduction
7.2.4 Allergan Revenue in Overactive Bladder Therapeutics Business (2017-2022)
7.2.5 Allergan Recent Development
7.3 Pfizer
7.3.1 Pfizer Company Details
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Overactive Bladder Therapeutics Introduction
7.3.4 Pfizer Revenue in Overactive Bladder Therapeutics Business (2017-2022)
7.3.5 Pfizer Recent Development
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Details
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Overactive Bladder Therapeutics Introduction
7.4.4 Johnson & Johnson Revenue in Overactive Bladder Therapeutics Business (2017-2022)
7.4.5 Johnson & Johnson Recent Development
7.5 Teva (Activas)
7.5.1 Teva (Activas) Company Details
7.5.2 Teva (Activas) Business Overview
7.5.3 Teva (Activas) Overactive Bladder Therapeutics Introduction
7.5.4 Teva (Activas) Revenue in Overactive Bladder Therapeutics Business (2017-2022)
7.5.5 Teva (Activas) Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Overactive Bladder Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Overactive Bladder Therapeutics Market Trends
Table 3. Overactive Bladder Therapeutics Market Drivers
Table 4. Overactive Bladder Therapeutics Market Challenges
Table 5. Overactive Bladder Therapeutics Market Restraints
Table 6. Global Overactive Bladder Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Overactive Bladder Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Overactive Bladder Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Overactive Bladder Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Overactive Bladder Therapeutics Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Overactive Bladder Therapeutics Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Overactive Bladder Therapeutics Revenue Share by Player, 2017-2022
Table 13. Global Overactive Bladder Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Overactive Bladder Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Overactive Bladder Therapeutics as of 2021)
Table 15. Top Players of Overactive Bladder Therapeutics in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Overactive Bladder Therapeutics Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Overactive Bladder Therapeutics Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Overactive Bladder Therapeutics Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Overactive Bladder Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Overactive Bladder Therapeutics Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Overactive Bladder Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Overactive Bladder Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Overactive Bladder Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Overactive Bladder Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Overactive Bladder Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Overactive Bladder Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Overactive Bladder Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Overactive Bladder Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Astellas Pharma Company Details
Table 31. Astellas Pharma Business Overview
Table 32. Astellas Pharma Overactive Bladder Therapeutics Product
Table 33. Astellas Pharma Revenue in Overactive Bladder Therapeutics Business (2017-2022) & (US$ Million)
Table 34. Astellas Pharma Recent Development
Table 35. Allergan Company Details
Table 36. Allergan Business Overview
Table 37. Allergan Overactive Bladder Therapeutics Product
Table 38. Allergan Revenue in Overactive Bladder Therapeutics Business (2017-2022) & (US$ Million)
Table 39. Allergan Recent Development
Table 40. Pfizer Company Details
Table 41. Pfizer Business Overview
Table 42. Pfizer Overactive Bladder Therapeutics Product
Table 43. Pfizer Revenue in Overactive Bladder Therapeutics Business (2017-2022) & (US$ Million)
Table 44. Pfizer Recent Development
Table 45. Johnson & Johnson Company Details
Table 46. Johnson & Johnson Business Overview
Table 47. Johnson & Johnson Overactive Bladder Therapeutics Product
Table 48. Johnson & Johnson Revenue in Overactive Bladder Therapeutics Business (2017-2022) & (US$ Million)
Table 49. Johnson & Johnson Recent Development
Table 50. Teva (Activas) Company Details
Table 51. Teva (Activas) Business Overview
Table 52. Teva (Activas) Overactive Bladder Therapeutics Product
Table 53. Teva (Activas) Revenue in Overactive Bladder Therapeutics Business (2017-2022) & (US$ Million)
Table 54. Teva (Activas) Recent Development
Table 55. Research Programs/Design for This Report
Table 56. Key Data Information from Secondary Sources
Table 57. Key Data Information from Primary Sources
List of Figures
Figure 1. Overactive Bladder Therapeutics Product Picture
Figure 2. Global Overactive Bladder Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Overactive Bladder Therapeutics Market Size 2017-2028 (US$ Million)
Figure 4. United States Overactive Bladder Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Overactive Bladder Therapeutics Market Size 2017-2028 (US$ Million)
Figure 6. United States Overactive Bladder Therapeutics Market Share in Global 2017-2028
Figure 7. Overactive Bladder Therapeutics Report Years Considered
Figure 8. Product Picture of Anticholinergics
Figure 9. Product Picture of Mirabegron
Figure 10. Product Picture of Botox
Figure 11. Global Overactive Bladder Therapeutics Market Share by Type in 2022 & 2028
Figure 12. Global Overactive Bladder Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 13. Global Overactive Bladder Therapeutics Market Share by Type (2017-2028)
Figure 14. United States Overactive Bladder Therapeutics Market Share by Type in 2022 & 2028
Figure 15. United States Overactive Bladder Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 16. United States Overactive Bladder Therapeutics Market Share by Type (2017-2028)
Figure 17. Product Picture of Idiopathic Overactive Bladder
Figure 18. Product Picture of Neurogenic Overactive Bladder
Figure 19. Global Overactive Bladder Therapeutics Market Share by Application in 2022 & 2028
Figure 20. Global Overactive Bladder Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 21. Global Overactive Bladder Therapeutics Market Share by Application (2017-2028)
Figure 22. United States Overactive Bladder Therapeutics Market Share by Application in 2022 & 2028
Figure 23. United States Overactive Bladder Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 24. United States Overactive Bladder Therapeutics Market Share by Application (2017-2028)
Figure 25. North America Overactive Bladder Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 26. U.S. Overactive Bladder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 27. Canada Overactive Bladder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Europe Overactive Bladder Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. Germany Overactive Bladder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. France Overactive Bladder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. U.K. Overactive Bladder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Italy Overactive Bladder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Russia Overactive Bladder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Overactive Bladder Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 35. China Overactive Bladder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Japan Overactive Bladder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. South Korea Overactive Bladder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. India Overactive Bladder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Australia Overactive Bladder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Taiwan Overactive Bladder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Indonesia Overactive Bladder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Thailand Overactive Bladder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Malaysia Overactive Bladder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Philippines Overactive Bladder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Latin America Overactive Bladder Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 46. Mexico Overactive Bladder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Brazil Overactive Bladder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Argentina Overactive Bladder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Overactive Bladder Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 50. Turkey Overactive Bladder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Overactive Bladder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. U.A.E Overactive Bladder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Astellas Pharma Revenue Growth Rate in Overactive Bladder Therapeutics Business (2017-2022)
Figure 54. Allergan Revenue Growth Rate in Overactive Bladder Therapeutics Business (2017-2022)
Figure 55. Pfizer Revenue Growth Rate in Overactive Bladder Therapeutics Business (2017-2022)
Figure 56. Johnson & Johnson Revenue Growth Rate in Overactive Bladder Therapeutics Business (2017-2022)
Figure 57. Teva (Activas) Revenue Growth Rate in Overactive Bladder Therapeutics Business (2017-2022)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Industry Market Size
